Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Middlehurst

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Mammalian Genome : Official Journal of the International Mammalian Genome Society|July 1, 1997
HOSEpipe--a WWW-hosted data management and analysis system for STS content mapping projectsM A Strivens, P Middlehurst, S D Brown, et al.
European Journal of Cancer (Oxford, England : 1990)|November 28, 2017
Plasma total cell-free DNA (cfDNA) is a surrogate biomarker for tumour burden and a prognostic biomarker for survival in metastatic melanoma patientsS Valpione, G Gremel, P Mundra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 7, 2019
Prediction and monitoring of relapse in stage III melanoma using circulating tumor DNAL Tan, S Sandhu, R J Lee, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Mammalian Genome : Official Journal of the International Mammalian Genome Society|July 1, 1997
HOSEpipe--a WWW-hosted data management and analysis system for STS content mapping projectsM A Strivens, P Middlehurst, S D Brown, et al.
European Journal of Cancer (Oxford, England : 1990)|November 28, 2017
Plasma total cell-free DNA (cfDNA) is a surrogate biomarker for tumour burden and a prognostic biomarker for survival in metastatic melanoma patientsS Valpione, G Gremel, P Mundra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 7, 2019
Prediction and monitoring of relapse in stage III melanoma using circulating tumor DNAL Tan, S Sandhu, R J Lee, et al.
Pageof 1